Mielóma multiplex: vizsgálatok itt: Görögország

In Görögország 39 Also abroad 703

39 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 12.. Ask the study team whether a trial fits you.

No phaseTaking people
A Study of Clinical Outcomes in Patients With Relapsed/Refractory Multiple Myeloma (RRMM) Treated With T-cell Redirectors Outside of Clinical Trials
Where
Alexandroupoli, Athens, Heraklion, Ioannina, Larissa, Thessaloniki
Életkor
18 év and over
People
900 worldwide
Run by
Janssen-Cilag Ltd.
See details and how to joinNCT06285318
2. fázisTaking people
A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Standard of Care in Participants With Relapsed-Refractory Multiple Myeloma (RRMM)
Where
Alexandroupoli, Athens, Ioannina, Thessaloniki
Életkor
18 év and over
People
200 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT07227311 · EU 2025-523117-28-00
1. fázisTaking people
A study to evaluate the Safety, Pharmacokinetics, and Activity of Subcutaneous Cevostamab (BFCR4350A) in Patients with Relapsed or Refractory Multiple Myeloma (CAMMA 3)
Where
Athens
Életkor
18 év and over
People
45 worldwide
Run by
Genentech Inc.
See details and how to join2023-503404-89-00
3. fázisTaking people
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
Where
Athens, Ioannina, Thessaloniki
Életkor
18 év and over
People
893 worldwide
Run by
Pfizer
See details and how to joinNCT05020236 · EU 2023-509208-14-00
1/2. fázisTaking people
A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
Where
Athens, Thessaloniki
Életkor
18 év and over
People
123 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT05714839 · EU 2022-501941-63-00
1/2. fázisTaking people
A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)
Where
Athens
Életkor
18 év and over
People
220 worldwide
Run by
Regeneron Pharmaceuticals
See details and how to joinNCT06292780 · EU 2023-507809-34-00
2. fázisTaking people
A multi-center, open-label, phase 2 study of Elranatamab in patients with high-risk smoldering multiple myeloma
Where
Athens
Életkor
18 év and over
People
105 worldwide
Run by
European Myeloma Network B.V.
See details and how to join2023-505775-70-00
1/2. fázisTaking people
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax (ABBV-453) Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
Where
Athens, Chaïdári, Thessaloniki
Életkor
18 év and over
People
88 worldwide
Run by
AbbVie Deutschland GmbH & Co. KG
See details and how to join2025-525105-20-00
No phaseTaking people
Digital Support for Multiple Myeloma Quality of Life
Where
Athens
People
108
Run by
CareAcross
See details and how to joinNCT07642362
3. fázisTaking people
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
Where
Alexandroupoli, Athens, Chaïdári, Patras, Thessaloniki
Életkor
18 év and over
People
520 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT06679101 · EU 2024-516030-35-00
3. fázisTaking people
A Study to Learn How Safe and How Well Linvoseltamab Works Compared to Standard Treatment in Adult Patients With Multiple Myeloma Who Are Not Eligible for Transplant
Where
Alexandroupoli, Athens, Thessaloniki
Életkor
18 év and over
People
1000 worldwide
Run by
European Myeloma Network B.V.
See details and how to joinNCT06932562 · EU 2024-519827-16-00
No phaseTaking people
Real-world Usage of HyQvia in Multiple Myeloma Adults With Secondary Immunodeficiency
Where
Athens, Thessaloniki
Életkor
18 év and over
People
75 worldwide
Run by
Takeda
See details and how to joinNCT05879757
No phaseTaking people
European Myeloma Network (EMN) Sample Project
Where
Athens, Thessaloniki
Életkor
18 év and over
People
6000 worldwide
Run by
European Myeloma Network B.V.
See details and how to joinNCT06237803
2. fázisTaking people
An Investigator-Initiated, Phase II, Multicenter, Open-Label, Single-Arm, Prospective Clinical Trial to Evaluate the Efficacy and Safety of Alternating Bortezomib-Based Regimens in Combination With DaratUMumab Followed by Maintenance With Daratumumab in the Frontline Setting of Primary Plasma CEll L
Where
Alexandroupoli, Athens, Piraeus, Thessaloniki
Életkor
18 év to 80 év
People
43
Run by
Hellenic Society of Hematology
See details and how to joinNCT06636552